Michael D. Bartberger
22Patents
8h-index
146Co-inventors
74Inventor score
Filing activity: May 24, 2005 → Feb 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10988485B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 22 | Active |
| US7666888B2 | Substituted azole aromatic heterocycles as inhibitors of 11β-HSD-1 | Chemistry; Metallurgy | 21 | Active |
| US11045484B2 | KRAS G12C inhibitors and methods of using the same | Human Necessities | 19 | Active |
| US11096939B2 | KRAS G12C inhibitors and methods of using the same | Chemistry; Metallurgy | 19 | Active |
| US9376425B2 | Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 12 | Active |
| US7872009B2 | Beta-Secretase modulators and methods of use | Chemistry; Metallurgy | 10 | Active |
| US7253196B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 10 | Expired |
| US7807700B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 8 | Active |
| US9296736B2 | Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US9593129B2 | Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 5 | Active |
| US8686011B2 | Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 | Chemistry; Metallurgy | 3 | Active |
| US8541592B2 | Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 | Chemistry; Metallurgy | 3 | Active |
| US11999730B1 | AKT1 modulators | Chemistry; Metallurgy | 1 | Active |
| US12209087B2 | AKT1 modulators | Chemistry; Metallurgy | 0 | Active |
| US7973047B2 | Beta-Secretase modulators and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11332459B2 | Benzimidazole derivatives and their uses | Chemistry; Metallurgy | 0 | Active |
| US8163766B2 | Beta-secretase modulators and methods of use | Chemistry; Metallurgy | 0 | Active |
| US8431563B2 | Compounds that interact with glucokinase regulatory protein for the treatment of diabetes | Chemistry; Metallurgy | 0 | Active |
| US11407721B2 | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US7745484B2 | Beta-secretase modulators and methods of use | Chemistry; Metallurgy | 0 | Active |
| US7838676B2 | Beta-secretase modulators and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12428416B2 | ERK inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.